D R A F T
National ART Surveillance System
NASS 2.0
(Proposed for 2016)
DRAFT
INITIAL REPORTING: PATIENT PROFILE (prosPEctive)
Quex ID |
LEAD QUESTION |
||
1 |
Date of cycle reporting (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| |
||
2 |
NASS Patient ID: |__|__|__|__| - |__|__|__|__| - |__|__| |
||
3 |
Patient Optional Identifiers Optional Identifier 1 |__|__|__|__|__|__|__| maximum 7 digits or characters |
||
|
Optional Identifier 2 |__|__|__|__|__|__|__| maximum 7 digits or characters |
||
4 |
Patient Date of Birth (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| |
||
5 |
Sex of patient: ⃝ Male ⃝ Female |
||
6 |
Cycle Start Date|__|__| - |__|__| - |__|__|__|__| |
||
|
RESIDENCY |
||
7 |
At the start of the cycle, is patient residency primarily in U.S.? ⃝Yes ⃝ No ⃝ Refused |
||
7A |
U.S. state of primary residence: City of primary residence U.S. zip code at primary residence |__|__|__|__|__| OR Country of primary residence: |
||
|
INTENT |
||
8 |
Intended type of ART? Select all that apply: IVF: Transcervical GIFT: Gametes to tubes ZIFT: Zygotes to tubes or TET: tubal embryo transfer Oocyte or embryo banking |
||
9 |
[SKIP IF NOT A BANKING ONLY CYCLE] |
If cycle is for banking only, specify banking type (select all that apply): Embryo banking Autologous oocyte banking Donor oocyte banking |
|
9A |
Indicate anticipated duration of oocyte banking SKIP IF EMBRYO BANKING ONLY Short term (<12 months) Long term (≥12 months) banking for fertility preservation prior to gonadotoxic medical treatments Long term (≥12 months) banking for other reasons |
||
9B |
Indicate anticipated duration of embryo banking SKIP IF OOCYTE BANKING ONLY Short term (<12 months)
Long term (≥12 months) banking for fertility preservation prior to gonadotoxic medical treatments Long term (≥12 months) banking for other reasons
|
||
10 |
Intended embryo source (select all that apply): [IF ONLY DONOR EMBRYOS SELECTED, SKIP TO #12] Patient embryos Donor embryos Fresh embryos Frozen embryos
|
||
10A |
If intent is to use FRESH EMBRYOS, specify intended oocyte source. Select all that apply: Fresh patient oocytes Frozen patient oocytes
Fresh donor oocytes Frozen donor oocytes
If intent is to use FROZEN EMBRYOS, specify intended oocyte source. Select all that apply: Fresh patient oocytes Frozen patient oocytes
Fresh donor oocytes Frozen donor oocytes Unknown (select only if oocyte source is unknown) |
||
10B |
If intend is to use donor embryos (select all that apply): Fresh embryos Frozen embryos |
||
11 |
Specify intended sperm source. Select all that apply. [SKIP IF DONOR EMBRYO IS INTENDED SOURCE] Partner Donor Patient, if male Unknown (select only if all sperm sources unknown for frozen) |
||
12 |
Pregnancy carrier Patient Gestational carrier None (oocyte or embryo banking cycle only) |
CYCLE INFORMATION (NOT prosPEctive FROM HERE FORWARD) |
|
Quex ID |
LEAD QUESTION |
13 |
Type of ART performed? Select all that apply: IVF: Transcervical GIFT: Gametes to tubes ZIFT: Zygotes to tubes or TET: tubal embryo transfer Oocyte or embryo banking |
14 |
Embryo source (select all that apply): [IF ONLY DONOR EMBRYOS SELECTED, SKIP TO #15] Patient embryos Donor embryos Fresh embryos Frozen embryos
|
14A |
If FRESH EMBRYOS were used, specify intended oocyte source. Select all that apply: Fresh patient oocytes Frozen patient oocytes
Fresh donor oocytes Frozen donor oocytes
If FROZEN EMBRYOS were used, specify intended oocyte source. Select all that apply: Fresh patient oocytes Frozen patient oocytes
Fresh donor oocytes Frozen donor oocytes Unknown (select only if oocyte source is unknown) |
PATIENT MEDICAL EVALUATION |
||||
|
REASON FOR ART |
|||
Quex ID |
LEAD QUESTION |
|||
15 |
Reason for ART (Select all that apply): Male infertility (select all that apply) |
|||
[SKIP IF MALE INFERTILITY NOT SELECTED] |
Azoospermia, obstructive Azoospermia, non-obstructive Oligospermia, severe (<5 million/mL) Oligospermia, moderate (5-15 million/mL) Low motility (<40%) Low morphology (4%)
|
|||
History of endometriosis Tubal ligation for contraception Current or prior hydrosalpinx |
||||
[SKIP IF HYDROSALPINX NOT SELECTED] |
Communicating Occluded Unknown |
|||
Other tubal disease (not current or historic hydrosalpinx) Ovulatory disorders |
||||
[SKIP IF OVULATORY DISORDER NOT SELECTED] |
PCO Other ovulatory disorders |
|||
Diminished ovarian reserve Uterine factor Preimplantation Genetic Diagnosis as primary reason for ART Oocyte or Embryo Banking as reason for ART Indication for use of gestational carrier |
||||
[SKIP IF GESTATIONAL CARRIER NOT INDICATED] |
|
|||
Recurrent pregnancy loss Other reasons related to infertility (specify) ________ _________ _______ Other reasons not related to infertility (specify) ________ _________ _______ Unexplained infertility |
||||
|
FEMALE PATIENT HISTORY AND PHYSICAL |
|||
16 |
[IF SEX OF PATIENT = MALE (FROM QUESTION #5) THEN SKIP #16-23]
Height: |__| Feet and/or |__|__| Inches or |__|__|__|__| Centimeters or Height unknown |
|||
17 |
Weight at the start of this cycle |__|__|__|__| Pounds or |__|__|__|__| Kilograms or Weight unknown |
|||
18 |
History of cigarette smoking: Did the patient smoke during the 3 months before the cycle started?
Yes No Unknown |
|||
19 |
Any prior pregnancies? ⃝Yes ⃝ No |
|||
19A |
[SKIP IF NO PRIOR PREGNANCIES] If prior pregnancies reported and couple is not surgically sterile, enter months or years attempting pregnancy since last clinical pregnancy |__|__|__| months and/or |__|__| years
[SKIP IF ANY PRIOR PREGNANCIES] If no prior pregnancies reported and couple is not surgically sterile, enter months attempting pregnancy |__|__|__| months and/or |__|__| years |
|||
19B |
SKIP IF NO PRIOR PREGNANCIES |
If prior pregnancies reported, how many |__|__| |
||
19C |
Number of prior full term births |__|__| |
|||
19D |
Number of prior preterm births |__|__| |
|||
19E |
Number of prior stillbirths |__|__| |
|||
19F |
Number of prior spontaneous abortions |__|__| |
|||
19G |
Number of ectopic pregnancies |__|__| |
|||
20 |
Number of prior stimulations for ART: |__|__| |
|||
21 |
Number of prior frozen ART cycles: |__|__| |
|||
21A |
SKIP IF NO PRIOR ART CYCLES |
Did any of the prior ART cycles result in a live birth? ⃝Yes ⃝ No |
||
22 |
Patient maximum FSH level (MIU/mls): |__|__|__| . |__|__| Or FSH unknown: |
|||
23 |
Most recent AMH level (ng/mL): |__|__|__| . |__|__| Or AMH unknown:
Date of most recent AMH level |__|__| - |__|__| - |__|__|__|__|
|
|||
SOURCE AND CARRIER PROFILES |
||||
|
OOCYTE SOURCE PROFILE |
|||
Quex ID |
LEAD QUESTION |
|||
24A |
[IF OOCYTE SOURCE = PATIENT AND DONOR, ANSWER THIS QUESTION] Youngest oocyte source
Patient [SKIP TO Q25] Donor [CONTINUE TO Q24) |
|||
24B |
OOCYTE SOURCE Date of Birth (mm/dd/yyyy): [FIELD PRE-FILLED IF OOCYTE SOURCE=PATIENT] |__|__| - |__|__| - |__|__|__|__|
OR age at earliest time oocytes were retrieved ____ |
|||
25 |
OOCYTE SOURCE Ethnicity: Select one: NOT Hispanic or Latino Hispanic or Latino Refused Unknown
|
|||
26 |
OOCYTE SOURCE Race (based on oocyte source self-report) Select all that apply: White Black or African American Asian Native Hawaiian or other Pacific Islander American Indian or Alaska Native |
|||
26A |
|
Select reason race not reported: ⃝ Refused ⃝ Unknown
|
|
PREGNANCY CARRIER PROFILE |
||
27 |
Pregnancy carrier Patient Gestational carrier None (oocyte or embryo banking cycle only) |
||
28 |
[IF CARRIER=NONE THEN SKIP 28-31] or [IF CARRIER=PATIENT AND OOCYTE SOURCE=PATIENT THEN SKIP 28-31]
Pregnancy carrier Date of Birth (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| OR age at time of transfer ____
|
||
29 |
Pregnancy carrier Ethnicity: Select one: ⃝ NOT Hispanic or Latino ⃝ Hispanic or Latino ⃝ Refused ⃝ Unknown
|
||
30 |
Pregnancy carrier Race (based on gestational carrier self report) Select all that apply: White Black or African American Asian Native Hawaiian or other Pacific Islander American Indian or Alaska Native |
||
30A |
Yes |
|
Select reason race not reported: ⃝ Refused ⃝ Unknown |
Quex ID |
LEAD QUESTION |
||||||
|
SPERM SOURCE PROFILE |
||||||
31 |
Specify sperm source. Select all that apply. Partner Donor Patient, if male Unknown (select only if all sperm sources unknown for frozen) |
||||||
32 |
SPERM source Date of Birth (mm/dd/yyyy):|__|__| - |__|__| - |__|__|__|__| [FIELD PRE-FILLED IF SPERM SOURCE=MALE PATIENT] Or Unknown |
||||||
33 |
SPERM source Ethnicity: Select one: ⃝ NOT Hispanic or Latino ⃝ Hispanic or Latino ⃝ Refused ⃝ Unknown |
||||||
34 |
SPERM source Race (based on patient self report) Select all that apply: White Black or African American Asian Native Hawaiian or other Pacific Islander American Indian or Alaska Native |
||||||
34A |
|
Select reason race not reported: ⃝ Refused ⃝ Unknown |
|||||
STIMULATION AND RETRIEVAL |
|||||||
Quex ID |
LEAD QUESTION |
||||||
|
OVARIAN STIMULATION AND MEDICATIONS |
||||||
35 |
Was there stimulation for follicular development? ⃝Yes ⃝ No
[IF NO STIMULATION OR FROZEN CYCLE, SKIP #36-39] |
||||||
36 |
Oral medication such as aromatase inhibitor or selective estrogen receptor modulator? ⃝Yes ⃝ No |
||||||
36A |
[SKIP IF NO ORAL MEDS] |
Clomiphene dosage (Total mgs): |__|__|__|__|__| . |__|__| Letrozole dosage (Total mgs) |__|__|__|__|__| . |__|__| Other (specify)_________ dosage |__|__|__|__|__| . |__|__| |
|||||
37 |
Medication(s) containing FSH? ⃝Yes ⃝ No |
||||||
37A |
[SKIP IF NO FSH MEDS] |
Short-acting FSH (Total IUs): |__|__|__|__|__| . |__|__| |
|||||
37B |
Long-acting FSH (Total mgs): |__|__|__|__|__| . |__|__| |
||||||
38 |
Medication(s) with LH/HCG activity? ⃝Yes ⃝ No |
||||||
Quex ID |
LEAD QUESTION |
||||||
39 |
GnRH Protocol Select the one primary protocol: ⃝ No GnRH protocol ⃝ GnRH Agonist Suppression ⃝ GnRH Agonist Flare ⃝ GnRH Antagonist Suppression |
||||||
|
CANCELLATION-I (open only for fresh cycles) |
||||||
40 |
[IF OOCYTE/EMBRYO SOURCE = FROZEN THEN SKIP 40-45]
Was this ART cycle canceled prior to retrieval? ⃝Yes ⃝ No |
||||||
40A |
[SKIP IF CYCLE NOT CANCELLED] |
Date cycle canceled (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| |
|||||
40B |
Select one primary reason cycle was canceled: Low ovarian response High ovarian response Inadequate endometrial response Concurrent illness Withdrawal only for personal reasons OTHER – specify ____________________________ |
||||||
|
[IF CYCLE CANCELLED, STOP HERE] |
||||||
|
FRESH OOCYTE RETRIEVAL |
||||||
41 |
Date retrieval performed (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| |
||||||
42 |
Total number of patient oocytes retrieved: |__|__| |
||||||
43 |
Total number of donor oocytes retrieved: |__|__| |
||||||
44 |
Use of retrieved oocytes Select all that apply: Used for this cycle Oocytes frozen for future use Oocytes shared with other patients Embryos frozen for future use |
||||||
44A |
[SKIP IF NO OOCYTES FROZEN] |
Number of FRESH oocytes frozen for future use: |__|__| |
|||||
|
COMPLICATIONS OF OVARIAN STIMULATION OR OOCYTE RETRIEVAL |
|
|||||
45 |
Were there any complications of ovarian stimulation or oocyte retrieval? ⃝Yes ⃝ No |
||||||
45A |
SKIP IF NO COMPLICATIONS |
Select all complications that apply: Infection Hemorrhage requiring transfusion Ovarian hyperstimulation requiring intervention or hospitalization Medication side effect Anesthetic complication Thrombosis Death of patient Other – specify ___________________ |
|||||
45B |
SKIP IF NO COMPLICATIONS |
Did the complication(s) require hospitalization? ⃝Yes ⃝ No
|
|||||
|
[IF OOCYTE BANKING CYCLE ONLY, STOP HERE] |
|
SPERM RETRIEVAL |
|||
46 |
Sperm status: Fresh Thawed Mix of fresh and thawed |
|||
47 |
Sperm source utilized: ⃝ Ejaculated ⃝ Epididymal ⃝ Testis ⃝ Electroejaculation ⃝ Retrograde urine ⃝ Donor ⃝ Unknown |
|||
LABORATORY INFORMATION |
||||
Quex ID |
LEAD QUESTION |
|||
|
MANIPULATION |
|||
48 |
Intracytoplasmic sperm injection (ICSI) performed on oocytes? ⃝ All oocytes ⃝ Some oocytes ⃝ No oocytes ⃝ Unknown |
|||
48A |
SKIP IF NO ICSI |
Indication for ICSI (select all that apply) ⃝ Prior failed fertilization ⃝ Poor fertilization ⃝ PGD ⃝ Abnormal semen parameters on day of fertilization ⃝ Low oocyte yield ⃝ Laboratory routine ⃝ Frozen cycle ⃝ Rescue ICSI ⃝ Other – specify ______________ |
||
49 |
In vitro maturation (IVM) performed on oocytes? ⃝ All oocytes ⃝ Some oocytes ⃝ No oocytes ⃝ Unknown |
|||
50 |
Pre-implantation genetic diagnosis or screening performed on embryos? ⃝ Yes ⃝ No ⃝ Unknown |
|||
50A |
SKIP IF PGD/PGS NOT PERFORMED OR UNKNOWN |
Total number of 2PN: |__|__| |
||
50B |
Reason(s) for pre-implantation genetic diagnosis or screening (Select all that apply): Either genetic parent is a known carrier of a gene mutation or a chromosomal abnormality Aneuploidy screening of the embryos Elective Gender Determination Other screening of the embryos |
|||
50C |
Technique(s) used for pre-implantation genetic diagnosis or screening (Select all that apply): Polar Body Biopsy Blastomere Biopsy Blastocyst Biopsy Unknown |
|||
51 |
Assisted hatching performed on embryos? ⃝ All embryos ⃝ Some embryos ⃝ No embryos ⃝ Unknown |
|||
52 |
Was this a research cycle? ⃝ Yes Enter SART approval code_____________ ⃝ No |
|||
52A |
SKIP IF NOT RESEARCH CYCLE |
Study type: Device study Protocol study Pharmaceutical study Laboratory technique Other research |
||
|
|
If ‘Other’, please specify ______________________________ |
||
|
[IF EMBRYO BANKING CYCLE ONLY, SKIP TO #59, THEN STOP] |
|||
TRANSFER |
||||
Quex ID |
LEAD QUESTION |
|||
|
CANCELLATION-II |
|||
53 |
Was a transfer attempted? ⃝Yes ⃝ No |
|||
53A |
|
Select one primary reason no transfer was attempted: Low ovarian response High ovarian response Failure to survive oocyte thaw Inadequate endometrial response Concurrent illness Withdrawal only for personal reasons Unable to obtain sperm specimen Insufficient embryos OTHER – specify ____________________________
|
|
[IF TRANSFER NOT ATTEMPTED, STOP HERE] |
||
|
GENERAL TRANSFER DETAILS |
||
54 |
Date of embryo transfer (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| |
||
55 |
Endometrial thickness at trigger: |__|__|mm |
||
|
FRESH EMBRYO TRANSFER DETAILS |
||
56 |
[IF NO FRESH EMBRYOS TRANSFERRED, SKIP #57-58] Number of FRESH embryos transferred to uterus: |__|__| |
||
57 |
[SKIP #57 FOR MIXED CYCLE] If only one fresh embryo was transferred to the uterus, was this an elective single embryo transfer? ⃝Yes ⃝ No |
||
58A-X |
Quality of embryo #1–X Good Fair Poor Unknown |
||
|
|
Date of oocyte retrieval for embryo #1-X |__|__| - |__|__| - |__|__|__|__| |
|
59 |
Number of FRESH embryos cryopreserved: |__|__| [STOP HERE FOR EMBRYO BANKING ONLY CYCLE] |
||
|
THAWED EMBRYO TRANSFER DETAILS |
|
|
60 |
Number of FROZEN or THAWED embryos available on day of transfer: |__|__| |
||
61 |
Number of THAWED embryos transferred to uterus: |__|__| [IF NO THAWED EMBRYOS TRANSFERRED, SKIP #62] |
||
62 |
[SKIP #63 FOR MIXED CYCLE] If only one thawed embryo was transferred to the uterus, was this an elective single embryo transfer? ⃝Yes ⃝ No |
||
62A-X |
Quality of embryo #1–X Good Fair Poor Unknown |
||
|
|
Date of oocyte retrieval for embryo #1-X |__|__| - |__|__| - |__|__|__|__| |
|
63 |
Number of THAWED embryos cryopreserved (re-frozen): |__|__| |
||
|
GIFT/ZIFT/TET TRANSFER DETAILS |
||
64 |
[SKIP IF IVF CYCLE] Number of oocytes or embryos transferred to the FALLOPIAN TUBE: |__|__| |
TREATMENT OUTCOME (only opens if transfer >0) |
|||
Quex ID |
LEAD QUESTION |
||
|
OUTCOME OF TRANSFER |
||
65 |
Outcome of treatment cycle: Not pregnant Biochemical only Clinical intrauterine gestation Ectopic Heterotopic Unknown
[IF NOT PREGNANT, BIOCHEMICAL ONLY, ECTOPIC, OR HETEROTOPIC, STOP HERE] |
||
66 |
|
Maximum fetal hearts on ultrasound performed before 7 weeks or prior to reduction: |__|__| No ultrasound performed before 7 weeks gestation |
|
66A |
[SKIP IF NO U/S] |
Date ultrasound with max. number of fetal hearts observed before 7 weeks (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| |
|
66B |
[SKIP IF NO U/S] |
If 2 or more fetal hearts, any monochorionic twins or multiples? ⃝Yes ⃝ No ⃝Unknown |
|
PREGNANCY OUTCOME (only opens if pregnancy = yes) |
|||
Quex ID |
LEAD QUESTION |
||
|
OUTCOME OF PREGNANCY |
||
67 |
Outcome of pregnancy: Live birth Spontaneous abortion Stillbirth Induced abortion Maternal death prior to birth Outcome unknown |
||
68 |
Date of pregnancy outcome (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| NOTE: If multiple births cover more than one date, enter date of first born. |
||
68A |
Method of delivery Vaginal Cesarean section |
||
69 |
Source of information confirming pregnancy outcome: (Select all that apply) Verbal confirmation from patient Written confirmation from patient Verbal confirmation from physician or hospital Written confirmation from physician or hospital |
||
|
BIRTH INFORMATION |
|
|
70 |
Number of infants born: |__|__| |
||
71A-X |
Birth Status infant #1-X
Live birth
|
||
72A-X |
Gender infant #1-X Male Female
|
||
73A-X |
Weight in pounds and ounces, or grams infant #1-X |__|__| lbs and |__|__| oz. OR |__|__|__|__| g OR Weight unknown |
||
74A-X |
Birth defects (select all that apply) infant #1-X None Cleft lip/palate Genetic defect/chromosomal abnormality Neural tube defect Cardiac defect Limb defect Other (specify) OR Unknown |
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Modified | 0000-00-00 |
File Created | 2021-01-22 |